Migraine Study

Now Enrolling


Study Objective

Phase 4, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to evaluate the effect of SPN-538 for the prophylaxis of migraine in pediatric patients 6 to 11 years old.


Key Requirements:

  • 6 years old - 11 years old 

Study Information

  • Compensation for time and travel up to 

  • Transportation can be arranged at no cost to you 

  • Study related exams at to cost


  • TOPAZ Clinical Research 2513 E. Semoran Blvd Apopka, FL 32703


Thank you for your interest in this clinical trial. Please complete the short questionnaire below or feel free to contact us directly at 407-703-4342.
Do you have history of migraines?

Your privacy is extremely important to us and this information is kept completely confidential. We take measures to protect the data  submitted on this website and we will never sell, trade or share your information with anyone.  

If you would rather speak directly to us do not hesitate to call 407-703-4342